Huasen Pharmaceuticals: Shareholder Liu Xiaoying plans to reduce his shareholding by no more than 3%.

Hua Sen Pharmaceutical announced that shareholder Liu Xiaoying, who holds more than 5% of the shares, plans to reduce his holdings through centralized bidding by no more than 4.176 million shares and through block trading by no more than 8.3519 million shares within 3 months from the disclosure date of the announcement to the day after the completion of the 15th trading day, with a total reduction not exceeding 12.5279 million shares, which is not more than 3% of the company's total share capital, due to personal financial needs.